+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum



The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum



Journal of Clinical Endocrinology and Metabolism 83(7): 2470-2478



Luteolysis is associated with tissue remodeling probably involving the matrix metalloproteinases (MMPs) and their specific tissue inhibitors (TIMPs). This study investigated the expression and localization of the major MMPs and TIMPs in the human corpus luteum throughout the luteal phase and after luteal rescue with hCG. Corpora lutea (n = 9) were collected at hysterectomy and were dated by serial urinary LH estimation. In addition, corpora lutea (n = 3) were collected from women who had received daily doubling doses of hCG to mimic the hormonal changes of early pregnancy. MMP-1, MMP-2, MMP-9, TIMP-1, TIMP-2, and TIMP-3 were investigated by zymography, reverse zymography, Northern blotting, and in situ hybridization. There was no change in the expression of MMP-1, TIMP-1, and TIMP-2 throughout the luteal phase or after luteal rescue. Little TIMP-3 could be detected in the corpus luteum. MMP-9 activity peaked in the early and late luteal phase. The expression and activity of MMP-2 were maximal in the late luteal phase. Exposure to hCG during luteal rescue in vivo was associated with a reduction (P < 0.05) in the expression and activity of MMP-2. Messenger ribonucleic acids (mRNAs) for MMP-1, MMP-2, and TIMP-2 were localized to the connective tissue stroma and the thecal-lutein cells of the corpus luteum. In contrast, TIMP-1 mRNA was localized to the granulosa-lutein cells, and MMP-9 mRNA was expressed in scattered cells within the steroidogenic and nonsteroidogenic cell layers. In conclusion, during maternal recognition of pregnancy, hCG prevents the normal increase in MMP-2 in the late luteal phase. MMPs can function in an environment containing large amounts of TIMP-1, as they have a different cellular localization.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047622286

Download citation: RISBibTeXText

PMID: 9661630

DOI: 10.1210/jcem.83.7.4950


Related references

The effect of luteal rescue on the expression of matrix metalloproteinases and their inhibitors in the human corpus luteum. Biology of Reproduction 52(SUPPL 1): 112, 1995

Expression of tissue inhibitor of metalloproteinases-1 in the human corpus luteum after luteal rescue. Journal of Endocrinology 148(1): 59-67, 1996

Dynamic expression of mRNAs for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Biology of Reproduction 64(Supplement 1): 288-289, 2001

Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Molecular Human Reproduction 8(9): 833-840, 2002

Coordinate changes in matrix metalloproteinase -2, membrane type-MMP and tissue inhibitor of metalloproteinase-1 and -2 expression of the human corpus luteum during luteal regression. Biology of Reproduction 58(SUPPL 1): 79, 1998

The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sciences 77(25): 3210-3221, 2005

Expression of gelatinase A and tissue inhibitor of metalloproteinases type 1 and their regulation by TNFalpha and IFNalpha during corpus luteum formation and luteal regression in rhesus monkey. Biology of Reproduction 62(Supplement 1): 139, 2000

Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum. Reproductive Biology and Endocrinology 1: 85, 2003

Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function. Molecular Human Reproduction 2(1): 26-30, 1996

Gonadotropin and steroid regulation of matrix metalloproteinases and their endogenous tissue inhibitors in the developed corpus luteum of the rhesus monkey during the menstrual cycle. Biology of Reproduction 70(1): 244-252, 2003

Expression and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases as a prognostic factor in advanced colorectal carcinomas. Oncology Reports 4(4): 701-705, 1997

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. Journal of Pathology 182(3): 347-355, 1997

Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 23(6): 1341-1344, 1996

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bovine luteal cell cultures. Biology of Reproduction 56(SUPPL 1): 196, 1997

Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy. Clinical and Experimental Nephrology 16(6): 863-874, 2013